Armadin
Armadin develops AI agents that test attack paths across enterprise systems and show defenders how connected weaknesses could be exploited.
$255.5MSeries B
ParticipantActivity from announced rounds
Armadin develops AI agents that test attack paths across enterprise systems and show defenders how connected weaknesses could be exploited.
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
Vals AI evaluates AI models on multi-step, economically valuable work across fields such as legal analysis, financial modeling and software engineering. Its private task-specific benchmarks, expert review and developer integrations help companies measure real-world capability and production risks.